About

Our purpose: delivering tomorrow’s precision medicines

Delivery is a massive bottleneck limiting the potential of novel therapeutics, including genetic medicines. Our non-viral delivery technology is poised to expand the clinical applications of emerging treatment modalities and address unmet needs across multiple therapeutic areas

Enabling Efficient Delivery of Novel Medicines

There is an urgent need to develop non-viral delivery technologies to enable patients to benefit from promising new therapeutic modalities. Our novel delivery platform has the potential to address this need and transform patients’ lives.

Proof of Biology Established

Vesigen’s ARMMs technology has demonstrated functional delivery of gene editing complexes and therapeutic RNA molecules to multiple cell types in vitro and in vivo. Use of standard unit operations and readily available starting materials support cost-effective manufacturability of ARMMs for clinical trials and commercialization.

Join our team

Explore current opportunities